Clinical Trials
11 trialsNCT05461430 2026-04-13
TraveraRTGx
Travera Inc
Completed
NCT06436807 2026-03-12
PMCF Study of the CE-marked Drainova® ArgentiC Catheter
ewimed GmbH
Completed
NCT02649894 2025-12-11
SWIFT
C. R. Bard
Phase NA Completed
NCT02227732 2025-11-26
A Pilot Study Evaluating the Safety and Effectiveness of a New Pleural Catheter for the Medical Management of Symptomatic, Recurrent, Malignant Pleural Effusions
C. R. Bard
Phase NA Completed
NCT01997190 2023-08-25
MpeTK01
Candel Therapeutics, Inc.
Phase 1 Completed
NCT04123886 2022-05-06
A Phase I Study Evaluating SCB-313(Recombinant Human TRAIL-Trimer Fusion Protein) for the Treatment of Malignant Pleural Effusion
Sichuan Clover Biopharmaceuticals, Inc.
Phase 1 Completed
NCT03869697 2022-02-02
Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleural Effusions
Clover Biopharmaceuticals, Ltd
Phase 1 Completed
NCT01327235 2014-08-01
Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 2 Completed
NCT02191540 2014-07-23
Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion Patients
Abnoba Korea
Phase 3 Completed
NCT00343291 2011-06-07
A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC
Eli Lilly and Company
Phase 2 Completed
NCT00099541 2009-11-23
Non-small Cell Lung Cancer Registry
Novartis
Phase 4 Completed